Mark D. Kelly

957 total citations · 1 hit paper
17 papers, 789 citations indexed

About

Mark D. Kelly is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Mark D. Kelly has authored 17 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Emergency Medicine and 5 papers in Virology. Recurrent topics in Mark D. Kelly's work include HIV-related health complications and treatments (7 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (5 papers). Mark D. Kelly is often cited by papers focused on HIV-related health complications and treatments (7 papers), HIV/AIDS Research and Interventions (6 papers) and HIV Research and Treatment (5 papers). Mark D. Kelly collaborates with scholars based in Australia, United States and Finland. Mark D. Kelly's co-authors include Andrew R. Lloyd, Susan Adams, Hassan M. Naif, Anthony L. Cunningham, Ronald J. Ellis, Desirée A. White, Robert K. Heaton, J. Allen McCutchan, Igor Grant and Thomas D. Marcotte and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and AIDS.

In The Last Decade

Mark D. Kelly

16 papers receiving 768 citations

Hit Papers

The HNRC 500-Neuropsychology of Hiv infection at differen... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Kelly Australia 8 539 330 168 134 115 17 789
Jonathan Worth United States 11 370 0.7× 453 1.4× 125 0.7× 113 0.8× 112 1.0× 16 912
K. R. Robertson United States 9 403 0.7× 266 0.8× 152 0.9× 64 0.5× 37 0.3× 13 654
Valerie Wojna Puerto Rico 17 614 1.1× 228 0.7× 235 1.4× 77 0.6× 46 0.4× 45 960
JT Becker United States 6 688 1.3× 393 1.2× 294 1.8× 56 0.4× 39 0.3× 7 871
Meredith E. Childers United States 10 339 0.6× 272 0.8× 142 0.8× 28 0.2× 67 0.6× 15 643
Monica H. Ultmann United States 7 318 0.6× 298 0.9× 130 0.8× 34 0.3× 59 0.5× 8 601
T. E. Nance‐Sproson United States 12 1.0k 1.9× 592 1.8× 390 2.3× 145 1.1× 55 0.5× 13 1.3k
Frederick W. Schaerf United States 9 215 0.4× 244 0.7× 80 0.5× 32 0.2× 203 1.8× 15 853
Robert A. Velin United States 8 599 1.1× 384 1.2× 257 1.5× 16 0.1× 148 1.3× 9 922
Jennifer Marquie‐Beck United States 14 441 0.8× 269 0.8× 214 1.3× 38 0.3× 61 0.5× 18 699

Countries citing papers authored by Mark D. Kelly

Since Specialization
Citations

This map shows the geographic impact of Mark D. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Kelly more than expected).

Fields of papers citing papers by Mark D. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Kelly. The network helps show where Mark D. Kelly may publish in the future.

Co-authorship network of co-authors of Mark D. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Kelly. A scholar is included among the top collaborators of Mark D. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Kelly. Mark D. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Broom, Jennifer, et al.. (2018). Addressing social influences reduces antibiotic duration in complicated abdominal infection: a mixed methods study. ANZ Journal of Surgery. 89(1-2). 96–100. 8 indexed citations
2.
Furuya‐Kanamori, Luis, Mark D. Kelly, & Samantha J. McKenzie. (2015). Risk of cardiovascular disease in HIV-positive Queensland men receiving combined antiretroviral therapy. Sexual Health. 12(4). 348–352.
3.
McManus, Hamish, Kathy Petoumenos, Mark D. Kelly, et al.. (2014). Determinants of Suicide and Accidental or Violent Death in the Australian HIV Observational Database. PLoS ONE. 9(2). e89089–e89089. 25 indexed citations
4.
McManus, Hamish, Jennifer Hoy, Ian Woolley, et al.. (2014). Recent Trends in Early Stage Response to Combination Antiretroviral Therapy in Australia. Antiviral Therapy. 20(2). 131–139. 4 indexed citations
5.
Furuya‐Kanamori, Luis, Mark D. Kelly, & Samantha J. McKenzie. (2013). Co-Morbidity, Ageing and Predicted Mortality in Antiretroviral Treated Australian Men: A Quantitative Analysis. PLoS ONE. 8(10). e78403–e78403. 14 indexed citations
6.
Kelly, Mark D., et al.. (2012). Tenofovir-associated proteinuria. AIDS. 27(3). 479–481. 12 indexed citations
7.
Cameron, Barbara, Carol Emerson, Cassy Workman, et al.. (2011). Alterations in Immune Function are Associated with Liver Enzyme Elevation in HIV and HCV Co-infection after Commencement of Combination Antiretroviral Therapy. Journal of Clinical Immunology. 31(6). 1079–1083. 6 indexed citations
8.
Post, Jeffrey J. & Mark D. Kelly. (2005). New developments in antiretroviral therapy for HIV infection. Australian Prescriber. 28(6). 146–149. 3 indexed citations
9.
Kelly, Mark D., Hassan M. Naif, Susan Adams, Anthony L. Cunningham, & Andrew R. Lloyd. (1998). Cutting Edge: Dichotomous Effects of β-Chemokines on HIV Replication in Monocytes and Monocyte-Derived Macrophages. The Journal of Immunology. 160(7). 3091–3095. 68 indexed citations
10.
Kelly, Mark D., Hassan M. Naif, Susan Adams, Anthony L. Cunningham, & Andrew R. Lloyd. (1998). Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages.. PubMed. 160(7). 3091–5. 86 indexed citations
11.
Kelly, Mark D., Andrew R. Lloyd, & Richard J. Kemp. (1996). 5.17 HIV, weight loss and wasting syndrome. The Medical Journal of Australia. 164(9). 549–550. 1 indexed citations
12.
Heaton, Robert K., Igor Grant, Nelson Butters, et al.. (1995). The HNRC 500-Neuropsychology of Hiv infection at different disease stages. Journal of the International Neuropsychological Society. 1(3). 231–251. 543 indexed citations breakdown →
14.
Kelly, Mark D., et al.. (1994). Neuropsychological Significance of IQ Summary Scores. International Journal of Neuroscience. 75(3-4). 175–179. 2 indexed citations
15.
Whaley, M. H., et al.. (1992). A Function of Pretraining Concentration. Journal of Cardiopulmonary Rehabilitation. 12(1). 42–50. 4 indexed citations
16.
Kelly, Mark D., et al.. (1990). Criterion-related validity of the WISC-R performance scale with the Stanford achievement test—Hearing-impaired edition. Journal of School Psychology. 28(2). 147–151. 9 indexed citations
17.
Kelly, Mark D.. (1990). Assessment of deaf children with neuropsychological measures. Cardinal Scholar (Ball State University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026